Desmoid tumor future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
 
Line 4: Line 4:


==Overview==
==Overview==
[[Angiogenesis inhibitor|Angiogenesis inhibitors]] and different [[chemotherapy agents]] are under [[Investigational new drug|investigation]] nowadays which might prove fruitful for treatment of [[Desmoid tumor|desmoid tumors]] in future. Furthermore, mutational analysis for [[Beta-catenin|beta-catenin gene]] may soon be used to predict the recurrence risk and to aid in designing the individual therapies.
[[Angiogenesis inhibitor|Angiogenesis inhibitors]] and different [[chemotherapy agents]] are under [[Investigational new drug|investigation]] nowadays which might prove fruitful for treatment of [[Desmoid tumor|desmoid tumors]] in future. Furthermore, [[Mutation|mutational]] [[analysis]]  for [[Beta-catenin|beta-catenin gene]] may soon be used to predict the recurrence risk and to aid in designing the individual therapies.


==Future or Investigational therapies==
==Future or Investigational therapies==
*Following investigational therapies might prove fruitful in future for treatment of desmoid tumors:
*Following [[Investigational new drug|investigational therapies]] might prove fruitful in future for treatment of [[Desmoid tumor|desmoid tumors]]:


===Angiogenesis inhibitors===
===Angiogenesis inhibitors===
*Newer substances which block the formation of new blood vessels feeding the tumors are under investigation and may be able to prevent the tumor growth in future
*Newer substances which block the formation of new [[blood vessels]] feeding the [[tumors]] are under [[Investigational New Drug|investigation]] and may be able to prevent the [[tumor]] [[growth]] in future


===Chemotherapy agents===
===Chemotherapy agents===
*Several chemotherapy drugs, or combination of drugs are being tested by researchers, that could prove to be most effective in treating desmoid tumors to avoid radical management via surgery
*Several [[Chemotherapy agents|chemotherapy drugs]], or combination of [[drugs]] are being tested by researchers, that could prove to be most effective in treating [[Desmoid tumor|desmoid tumors]] to avoid radical management via [[surgery]]


===Mutations in the gene for beta-catenin===
===Mutations in the gene for beta-catenin===
*Beta-catenin gene mutations have been found to commonly occur in desmoid tumor
*[[Beta-catenin]] [[gene]] [[mutations]] have been found to commonly occur in [[desmoid tumor]]
*Mutational analysis may be used soon in order to predict the recurrence risk and to aid in designing the individual therapies
*[[Mutation|Mutational]] [[analysis]] may be used soon in order to predict the recurrence risk and to aid in designing the individual therapies


==Source==
==Source==

Latest revision as of 16:08, 13 March 2019

Desmoid tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Desmoid tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Angiogenesis inhibitors and different chemotherapy agents are under investigation nowadays which might prove fruitful for treatment of desmoid tumors in future. Furthermore, mutational analysis for beta-catenin gene may soon be used to predict the recurrence risk and to aid in designing the individual therapies.

Future or Investigational therapies

Angiogenesis inhibitors

Chemotherapy agents

Mutations in the gene for beta-catenin

Source

Reference

Template:WikiDoc Sources